PLATINUM INDUSTRIES Q2 FY27 CONCALL: TARGETS 35% REVENUE CAGR OVER 3 YEARS & 13–15% EBITDA MARGIN IN FY28; ₹25–30 CR FY27 EGYPT REVENUE, 60,000 MTPA CAPACITY BY MARCH 2027 & PHARMA CONTRIBUTION FROM Q1 FY28